Madrid, EvaBarros Monge, Manuel JUrrútia, GerardRoqué I Figuls, MartaPérez Bracchiglione, JavierVargas Peirano, ManuelLoézar Hernández, Cristóbal NicolásBonfill Cosp, Xavier2022-11-302022-11-302018Madrid E, Barros Monge MJ, Urrútia G, Roqué i Figuls M, Pérez Bracchiglione J, Vargas Peirano M, Loézar Hernández CN, Bonfill Cosp X. Taxanes for advanced non‐small cell lung cancer. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No.: CD013075. DOI: 10.1002/14651858.CD013075. Accessed 25 November 2022.http://repositoriobibliotecas.uv.cl/handle/uvscl/7402This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of taxanes as part of a combined or single‐agent therapy versus other agents or best supportive care as first‐ or second‐line treatment for advanced non‐small cell lung cancer (NSCLC). A secondary objective is to assess different modes or schemes of administration of taxanes in patients with this disease.Articulohttps://doi.org/10.1002/14651858.CD013075